Clearance Summary
O2 Concepts Oxlife Independence Model 301-0001 received FDA 510(k) clearance under submission number K182454, sponsored by O2 Concepts, LLC. The device was reviewed via the Traditional premarket notification pathway and assigned to the Anesthesiology review panel. The statutory decision date of record is 2018-12-20.
- Submission: K182454
- Applicant / Sponsor: O2 Concepts, LLC
- Clearance pathway: Traditional
- Review panel: Anesthesiology
- Device class: Class II
- Regulation citation: 21 CFR 868.5440
- Decision date: 2018-12-20
Classification & Regulation
This clearance is catalogued under FDA product code CAW and 21 CFR 868.5440, within the Anesthesiology review panel as a Class II device.